Star Cement (540575) Q4 11/12 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 11/12 earnings summary
26 Oct, 2026Executive summary
Consolidated net sales rose 15.22% to ₹56,495.95 lakh, while EBITDA declined 3.95% and PAT fell to ₹8,982.47 lakh from ₹12,062.04 lakh.
Cement production increased 14.53% to 1,103,800 MT and sales volume rose 13.96% to 1,106,422 MT; North-East market share reached 18.7%.
Expansion at Lumshnong and Guwahati was progressing toward FY2012-13 commercial start-up, backed by rising regional demand and a persistent supply gap.
Financial highlights
Consolidated net sales were ₹56,495.95 lakh versus ₹49,032.56 lakh; consolidated EBITDA was ₹14,548.29 lakh, down 3.95%.
Consolidated PBT declined to ₹9,097.31 lakh from ₹11,730.58 lakh; PAT after minority interest was ₹8,982.47 lakh versus ₹12,062.04 lakh.
Consolidated exceptional items were a ₹741.73 lakh charge, versus ₹168.17 lakh income in FY2010-11.
Standalone net sales were ₹33,746.69 lakh versus ₹32,556.21 lakh; standalone PAT fell to ₹4,047.56 lakh from ₹8,345.83 lakh.
Outlook and guidance
Both the 1.75 MTPA Lumshnong clinker unit and 1.60 MTPA Guwahati grinding unit were expected to begin commercial production in FY2012-13.
Cement demand was expected to grow 8% in FY2012-13; the national outlook cited GDP growth of 7.5%-8% and increased infrastructure and low-cost housing spending.
Planned energy measures included additional VFDs, crusher upgrades, improved kiln sealing and ISO 50001 energy-management implementation.
Latest events from Star Cement
- Revenue rose, consolidated profit fell, and the ₹1,500 crore fund raise was deferred.540575
Q2 26/27 - Record FY10 earnings and expansion plans face rising input-cost pressure.540575
Q4 09/10 - Record output and expansion plans countered cost pressure and softer consolidated profits.540575
Q4 10/11 - New capacity and market expansion plans amid sharply lower profit and rising costs.540575
Q4 12/13 - New capacity drove rapid growth, but higher financing and depreciation costs kept FY14 in loss.540575
Q4 13/14 - Sales volume rose 33% and EBITDA 85% as capacity expansion drove growth.540575
Q4 14/15 - Volumes and revenue grew, but lower realizations and higher costs cut EBITDA.540575
Q4 15/16 - Record profits and sharp debt reduction set the stage for capacity-led growth.540575
Q4 17/18 - Profit rose despite a weak market, while regional sales and capacity expansion advanced.540575
Q4 16/17